Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma of the Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Testing effectiveness (Phase 2)Study completedNCT00101608
What this trial is testing

Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Transitional Cell CarcinomaBladder NeoplasmsKidney Neoplasms+3 more
Bristol-Myers Squibb 150
Large-scale testing (Phase 3)Study completedNCT00389155
What this trial is testing

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Who this might be right for
Bladder CancerTransitional Cell CarcinomaMetastasis
Bristol-Myers Squibb 34
Not applicableStudy completedNCT01395225
What this trial is testing

Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Carcinoma
University of British Columbia 32
Early research (Phase 1)Ended earlyNCT01282333
What this trial is testing

Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+11 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Study completedNCT00506155
What this trial is testing

Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)UnknownNCT04492293
What this trial is testing

An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer

Who this might be right for
Bladder Urothelial Cancer
Beijing InnoCare Pharma Tech Co., Ltd. 115
Large-scale testing (Phase 3)Study completedNCT00867347
What this trial is testing

Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer

Who this might be right for
Bladder Cancer
Institute of Cancer Research, United Kingdom 45
Large-scale testing (Phase 3)Study completedNCT00014274
What this trial is testing

Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
European Organisation for Research and Treatment of Cancer - EORTC 238
Testing effectiveness (Phase 2)UnknownNCT03549715
What this trial is testing

NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma

Who this might be right for
Infiltrating Bladder Urothelial Carcinoma
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 121
Testing effectiveness (Phase 2)Study completedNCT00794950
What this trial is testing

Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Tract Urothelial Carcinoma
University of Michigan 43
Testing effectiveness (Phase 2)UnknownNCT03715985
What this trial is testing

Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)

Who this might be right for
Malignant Melanoma, MetastaticNon Small Cell Lung Cancer MetastaticBladder Urothelial Carcinoma, Metastatic
Herlev Hospital 12
Early research (Phase 1)Study completedNCT04440943
What this trial is testing

The PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerBreast CancerGastric Cancer+11 more
Celldex Therapeutics 27
Large-scale testing (Phase 3)UnknownNCT00146276
What this trial is testing

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Who this might be right for
Bladder CancerCarcinoma, Transitional Cell
Association of Urologic Oncology (AUO) 178
Testing effectiveness (Phase 2)Study completedNCT04004221
What this trial is testing

Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer

Who this might be right for
Locally Advanced or Metastatic Urothelial Bladder Cancer
BeiGene 113
Large-scale testing (Phase 3)Looking for participantsNCT07129993
What this trial is testing

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CancerBladder Cancer
Daiichi Sankyo 630
Testing effectiveness (Phase 2)Study completedNCT01023958
What this trial is testing

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 50
Testing effectiveness (Phase 2)Study completedNCT01089088
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Cardiff University 63
Testing effectiveness (Phase 2)Ended earlyNCT02401542
What this trial is testing

Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Cell CarcinomaUrinary Bladder DiseaseUrological Diseases
Rainier Therapeutics 71
Not applicableEnded earlyNCT05700227
What this trial is testing

Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Urothelial Carcinoma
Varian, a Siemens Healthineers Company 2
Next Page